科源制药(301281.SZ)：前三季净利润3147万元 同比下降20.69%

Core Viewpoint - Key financial metrics for Koyuan Pharmaceutical indicate a decline in both revenue and net profit for the first three quarters of the year, suggesting potential challenges in the company's performance [1] Financial Performance - The company's operating revenue for the first three quarters reached 300 million, representing a year-on-year decrease of 8.52% [1] - The net profit attributable to shareholders of the listed company was 31.47 million, down 20.69% year-on-year [1] - The net profit after deducting non-recurring gains and losses was 22.65 million, reflecting a year-on-year decline of 15.84% [1]